Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
14 hedge funds and large institutions have $25.7K invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
13% less funds holding
Funds holding: 16 → 14 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
76% less capital invested
Capital invested by funds: $109K → $25.7K (-$83.2K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$460 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$41.2K |
| 2 |
CF
Cantor Fitzgerald
New York
|
-$1.34K |
| 3 |
KL
KIM LLC
Wichita,
Kansas
|
-$813 |
CTV.WS Hedge Fund Activity: Q3 2024 in Review
14 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q3 2024, worth a combined $25.7K — down 76% from $109K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CTV.WS and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Cowen and Company, opening a new position worth an estimated $460. The largest seller was LMR Partners, exiting entirely with an estimated $41.2K sold.
- 14 institutional investors held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q3 2024, down from 16 in Q2 2024.
- Funds reported $25.7K of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q3 2024, down 76% quarter-over-quarter.
- 1 fund opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q3 2024 and 3 closed out, a net change of -2 holders.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share buyer in Q3 2024 was Cowen and Company, an estimated $460 added.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q3 2024 was LMR Partners, an estimated $41.2K sold.
Based on aggregated 13F filings for Q3 2024.